Interest of beta 2-microglubulin determination in chronic hemodialysis patients
DOI:
https://doi.org/10.30574/gscarr.2021.9.2.0053Keywords:
Chronic Hemodialysis, Beta-2microglubuline, Age, Diuresis, Hemodialysis, Duration of membrane, Type amyloidosis, SCCAbstract
The amylase beta 2-microglobulin (β2m) is a common complication of long-term hemodialysis, mainly responsible for osteo-articular manifestations including carpal tunnel syndrome (CTS). With the aim to study the various parameters involved in the increase of and determine the interest of dosage, we conducted a cross-sectional study of 104 chronic hemodialysis patients for more than 6 months. The mean age of patients was 52.82 years with a male predominance (62.5%). 61, 3% of our patients are anuric. They all have intermittent hemodialysis at 12 hours per week using a low permeability membrane in 52% of patients. The average age of dialysis layout is 42, 18 years. The mean duration of hemodialysis was 74 months. The mean serum β2m is 35, 24 mg / l. regarding complications, there were four confirmed cases of carpal tunnel syndrome and 12 deaths. Our study objectify the parameters involved in the increase of β2m: The current age, age advanced dialysis layout, lack of urine output, low permeability membrane and extended duration hemodialysis. Increased serum levels of β2m in our hemodialysis demonstrate the poor treatment of middle molecules. Its reduction can be made by improving the quality of dialysis and will avoid all the complications.
Metrics
References
Kuchle C, Fricke H, Held E, Schiff H. high-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis. Am J Nephrol. 1996; 16(6):484-488.
Cheung AK, Greene T, Leypoldt JK, et al. Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol 2008:3:69-77. 3- Al-Taee IK, Al-Safar JJ, Al-Falahi YS, Al- Shamma IA. The clinical significance of Bé- microglobulin in end-stage renal disease. Saudi J Kidney Dis Transpl. 2003; 14(4):492-6.
Alhomrany MA, Khan MR, Adzaku F, Harding MG. Carpel tunnel syndrome in hemodialysis patients:Earlydetection byelectroneurophysiological studies.2001;6(6): 259-62.
SenjiOkuno, E.Ishimura, Kaori Kohno: Serum B2-microglobulin level is a significant predictor of mortality in maintenance hemodialysis patients. Nephrol Dial transplant. 2009; 24:571-577.
Yamamoto S, Junichiro JK, Narita A, Naiki H, Fumitake G. Recent progress in understanding dialysis-related amyloidosis. Bone. 2009;45:S39–S42.
Van Ypersele de Strihou C, Jadoul M, Malghim J, Maldague B, Jamart J, and the working party on dialysis Amyloidosis. Effect of dialysis Amyloidosis.Kidney Int. 1991; 39:1012-1019.
Sivri A, Celiker R, Sungur C, et al. Carpal tunnel syndrome: a major complication in hemodialysis patients. Scand J Rheumatol. 1994; 23(5):287-9.
Poulenas I, Spertini F, Wauters J.P. Syndrome du tunnel carpien chez les patient’s enhémodialysechronique.Complication tardive de la fistuleartérioveineuse? Ann Chir Main. 1983; 2:244-249.
Horl WH, Haag-Weber M, Georgopoulos A, Block LH.Physiocochemical characterization of a polypeptide persent in uremic serum that inhibits the biological activity of polymorphonuclear cells. Proc Natl acadSci USA.1990; 87:6353-6357.
Traut M, Haufe CC, Eismann U, Deppisch RM, Stein G, Wolf G, Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with low-flux membranes contributed to reduced beta-2-mircoglobulin concentrations. Blood Purif 2007; 25: 432 - 40.
Jeloka T, Mathur G, Kaur R, Kohli R, Singh NP, Rizvi SN. B2 microglobulin in chronic renal failure and effect of different dialyzer membrane on its clearance. Indian J Nephrol 2001; 11: 160 - 4
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.